Pfizer says impact of Zantac litigation is unlikely to be material
Pfizer says impact of Zantac litigation is unlikely to be material
276
views
After a ~3% decline in its share price on Thursday amid concerns over the legal overhang related to recalled heartburn medication Zantac, Pfizer (PFE) sought to rule out a...
Pfizer says impact of Zantac litigation is unlikely to be materialAug. 11, 2022 11:47 PM ETPfizer Inc. (PFE)HLN, GSKBy: Dulan Lokuwithana, SA News Editor2 Comments

Pfizer Canada head office in Kirkland, Quebec, Canada.

JHVEPhoto/iStock Editorial via Getty Images

Comments

https://stocktradingwebsites.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!